{
  "id": 6774453,
  "title": "Yarrow brings in more cash; AbbVie drug succeeds in menstrual migraine trial",
  "url": "https://urgent.news/2026/09/11/yarrow-brings-in-more-cash-abbvie-drug-succeeds-in-menstrual-migraine",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-11T15:28:37.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/yarrow-brings-in-more-cash-abbvie-drug-succeeds-in-menstrual-migraine-trial/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about Sino Biopharm and AtomVie. Yarrow gets more money: New Haven-based Yarrow Bioscience priced a $150 million offering at $26 per share {$YARW}, about $2.50 below its Thursday closing ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}